Shares of Canopy Growth Corp (TSE:WEED - Get Free Report) hit a new 52-week high on Tuesday . The company traded as high as C$16.75 and last traded at C$15.57, with a volume of 5909081 shares traded. The stock had previously closed at C$11.36.
Wall Street Analyst Weigh In
A number of analysts recently commented on the company. Bank of America dropped their price target on Canopy Growth from C$7.00 to C$4.00 in a research note on Wednesday, February 14th. Jefferies Financial Group dropped their target price on shares of Canopy Growth from C$7.28 to C$4.90 and set a "hold" rating for the company in a research report on Tuesday, February 27th. Finally, Sanford C. Bernstein increased their price target on shares of Canopy Growth from C$1.49 to C$6.70 in a research note on Tuesday, January 30th.
Check Out Our Latest Stock Analysis on Canopy Growth
Canopy Growth Stock Performance
The business's fifty day moving average is C$8.26 and its two-hundred day moving average is C$5.08. The company has a current ratio of 1.79, a quick ratio of 2.32 and a debt-to-equity ratio of 127.28. The company has a market capitalization of C$1.86 billion, a PE ratio of -0.73, a price-to-earnings-growth ratio of -0.01 and a beta of 1.63.
About Canopy Growth
(
Get Free Report)
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Canopy Growth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.
While Canopy Growth currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
